Funding
Who raised, when, and from whom? Explore announced rounds, including emerging Indian companies, and company-reported SEC notices. Each amount keeps its original source and date.
330 filings · Form D notices of private raises, 2024-01-02 to 2026-03-31
Foment Bio, Inc.Pharmaceuticals
Montgomery, Texas · founded 2023 · Equity · 12 investors · Marc Penn, Ben Chlebina
Aveta Biomics, Inc.Pharmaceuticals
Bedford, Massachusetts · Equity · 36 investors · S. P. Kothari, Parag Mehta
Curevo, Inc.Pharmaceuticals
Bothell, Washington
NextEvo, Inc.Pharmaceuticals
Conshohocken, Pennsylvania · Equity · 1 investors · William McComb, John McDonagh
IVIEW Therapeutics, Inc.Pharmaceuticals
Cranbury, New Jersey · Equity · 4 investors · Bo Liang, Qi Zhu
Akava Therapeutics Inc.Pharmaceuticals
Winnetka, Illinois · Equity, Options, Convertible · 1 investors · Brendan MacMillan, Joseph Nolan
Vitalis Therapeutics, Inc.Pharmaceuticals
New York, New York · Equity · 14 investors · Joseph Habboushe
Neuro-Innovators LLCPharmaceuticals
Sewickley, Pennsylvania · founded 2021 · Equity, Options · 6 investors · John Howison Schroeder
Phlow Corp.Pharmaceuticals
Richmond, Virginia · Equity · 9 investors · David Ryan, Melinda Hancock
60 DEGREES PHARMACEUTICALS, INC.Pharmaceuticals
Washington, District Of Columbia · founded 2022 · Options · 4 investors · Geoffrey Dow
Lomond Therapeutics Holdings, Inc.Pharmaceuticals
Dover, Delaware · founded 2021 · Equity · 28 investors · Carl Gordon, Iain Dukes
Lomond Therapeutics Holdings, Inc.Pharmaceuticals
Dover, Delaware · founded 2021 · Equity · 28 investors · Carl Gordon, Iain Dukes
AXIAL THERAPEUTICS, INC.Pharmaceuticals
Woburn, Massachusetts · Equity, Options · 29 investors · Sarah Meibusch, Scott Brun
60 DEGREES PHARMACEUTICALS, INC.Pharmaceuticals
Washington, District Of Columbia · founded 2022 · Options · 4 investors · Geoffrey Dow
Sea Pharmaceuticals, LLCPharmaceuticals
Cambridge, Massachusetts · Equity · 16 investors · Nabil Elkouh, Eric Olson
DepYmed Inc.Pharmaceuticals
Farmingdale, New York · Equity, Convertible · 1 investors · Peter Young, Andreas Grill
Seneca Therapeutics, Inc.Pharmaceuticals
Blue Bell, Pennsylvania · Equity, Options, Convertible · 68 investors · Cuong Do, Mark Kerschner
BTB Therapeutics, Inc.Pharmaceuticals
Escondido, California · founded 2024 · Equity, Debt · 10 investors · Takashi Kiyoizumi
NanoPharmaceuticals LLCPharmaceuticals
Troy, New York · Equity · 12 investors · Paul Davis, Eliza McKinney
Kairos Pharma, LTD.Pharmaceuticals
Los Angeles, California · Options, Convertible · 1 investors · Hyun Bae, Neil Bhowmick
Precision Genetics, Inc.Pharmaceuticals
Greenville, South Carolina · Options, Convertible · 1 investors · Nathan Wilbourne
OS Therapies IncPharmaceuticals
Grasonville, Maryland · Equity, Options, Convertible · 34 investors · Avril McKean Dieser, John Ciccio
Indaptus Therapeutics, Inc.Pharmaceuticals
New York, New York · founded 2021 · Equity, Options, Convertible, 2,109,383 shares of Common Stock and common warran · 16 investors · Roger Pomerantz, Anthony Maddaluna
Immunovant, Inc.Pharmaceuticals
New York, New York · Equity · 11 investors · Christopher Van Tuyl, Michael Geffner
Acurx Pharmaceuticals, Inc.Pharmaceuticals
Staten Island, New York · Options, Convertible · 12 investors · Joseph Scodari, Carl Sailer
Rivus Pharmaceuticals, Inc.Pharmaceuticals
Charlottesville, Virginia · Equity · 7 investors · Robert Schott, Shaharyar Khan
Balanced Pharma IncPharmaceuticals
Cornelius, North Carolina · founded 2020 · Equity · 2 investors · John Keadle, Atif Zia
Galera Therapeutics, Inc.Pharmaceuticals
Malvern, Pennsylvania · Equity, Options · 8 investors · Nancy Chang, J. Sorensen
Cambrian BioPharma IncPharmaceuticals
New York, New York · Options, Simple Agreement for Future Equity · 30 investors · Christian Angermayer, Maryanna Saenko
Galera Therapeutics, Inc.Pharmaceuticals
Malvern, Pennsylvania · Equity · 18 investors · Michael Friedman, Joel Sussman